Performance vs S&P 500

03
Tracked Q1 2025–Q2 2026 +253.1%
S&P 500 total return (same window) +37.0%
Excess return +216.1%

Annualized: +174.5% · S&P 500: +28.7%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 96.7% · Options excluded: 2.6%

Sector breakdown

04
Healthcare 93.5%
Other/Unmapped 6.5%

Full portfolio 42 positions

05
Type Streak 8Q trend
ABVX Abivax SA - American Depositary Shares $53,304,000 10.07% 400,000 Call option Up ×1
VOR Vor Biopharma Inc. - Common Stock $31,297,000 5.91% 1,700,000 $77,000 Down ×1
ABVX Abivax SA - American Depositary Shares $27,226,884 5.15% 204,314
IBRX ImmunityBio, Inc. - Common Stock $26,272,004 4.97% 3,000,800 Put option $3,255,868
VERA Vera Therapeutics, Inc. - Class A Common Stock $25,781,873 4.87% 600,836 $17,762,103 Up ×1
ZURA Zura Bio Limited - Class A Ordinary shares $24,873,987 4.70% 4,215,930 $-210,797
ALMS Alumis Inc. - Common Stock $24,089,557 4.55% 856,061 $5,230,533
SLGL Sol-Gel Technologies Ltd. - Ordinary Shares $20,341,273 3.84% 274,363 $-1,393,764
RARE Ultragenyx Pharmaceutical Inc. - Common Stock $20,034,000 3.79% 600,000 Put option Up ×1
DFTX Definium Therapeutics, Inc. - Common Shares $19,992,000 3.78% 425,000 Up ×1
ANNX Annexon, Inc. - common stock $19,985,000 3.78% 3,500,000 $6,135,000 Up ×1
ORKA Oruka Therapeutics, Inc. - Common Stock $17,447,516 3.30% 183,330 $8,455,179
MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares $16,662,679 3.15% 855,813 $7,342,679 Up ×1
SGMT Sagimet Biosciences Inc. - Series A Common Stock $15,691,382 2.97% 2,029,933 Up ×1
CTNM Contineum Therapeutics, Inc. - Common stock $15,103,074 2.85% 921,481 $4,652,488 Up ×2
IMMX Immix Biopharma, Inc. - Common Stock $13,172,489 2.49% 1,277,642 $9,983,989 Up ×1
CLYM Climb Bio, Inc. - Common Stock $13,040,000 2.46% 1,000,000 $3,901,209 Down ×1
AMLX Amylyx Pharmaceuticals, Inc. - Common Stock $12,572,000 2.38% 700,000 $-11,753,000 Down ×1
NKTR Nektar Therapeutics - Common Stock $12,216,750 2.31% 175,000 $-10,552,043 Down ×1
NGNE Neurogene Inc. - Common Stock $11,076,061 2.09% 352,180 $996,061 Down ×1
LBRX LB Pharmaceuticals Inc - Common Stock $10,295,408 1.95% 317,221 $2,897,408 Up ×1
IRD Opus Genetics, Inc. - Common Stock $8,097,469 1.53% 1,970,187 $6,621,722 Up ×1
EPRX Eupraxia Pharmaceuticals Inc. - Common Stock $7,932,000 1.50% 1,200,000 $-756,000
DRUG Bright Minds Biosciences Inc. - common stock $7,694,131 1.45% 109,603 $-8,359,269 Down ×1
IFRX InflaRx N.V. - Common Stock $6,824,288 1.29% 3,046,557 Up ×1
RLMD Relmada Therapeutics, Inc. - Common Stock $5,827,374 1.10% 842,106 $-33,684
Unknown issuer (CUSIP: G50765109) $5,680,000 1.07% 500,000 Up ×1
CGEM Cullinan Therapeutics, Inc. - Common Stock $5,463,000 1.03% 300,000 $1,200,000
ALT Altimmune, Inc. - Common Stock $5,293,345 1.00% 1,741,232 Up ×1
Unknown issuer (CUSIP: G0375M101) $5,080,000 0.96% 500,000 Up ×1
RZLT Rezolute, Inc. - Common Stock (NV) $4,949,407 0.94% 951,809 $2,046,390
SLN Silence Therapeutics Plc - American Depository Share $4,941,000 0.93% 450,000 $-436,977 Down ×1
PALI Palisade Bio, Inc. - Common Stock $4,775,272 0.90% 2,284,819 $-1,184,803 Down ×1
EVMN Evommune, Inc. Common Stock $4,319,250 0.82% 325,000 $-3,152,500
Unknown issuer (CUSIP: 811292309) $3,843,268 0.73% 944,292 Up ×1
GALT Galectin Therapeutics Inc. - Common Stock $3,712,000 0.70% 800,000 Call option $1,480,000
ELVN Enliven Therapeutics, Inc. - Common Stock $3,552,500 0.67% 70,000 Up ×1
HUMA Humacyte, Inc. - Common Stock $2,926,500 0.55% 3,750,000 $651,375
RNTX Rein Therapeutics, Inc. - Common Stock $2,678,000 0.51% 2,575,000 Up ×1
DBVT DBV Technologies S.A. - American Depositary Shares $2,573,258 0.49% 156,906
AVXL Anavex Life Sciences Corp. - Common Stock $1,350,167 0.26% 521,300 Call option $-250,224
PMN ProMIS Neurosciences Inc. - Common Shares $1,133,734 0.21% 86,150 $-3,583,071 Down ×1

Biggest new bets

09

New positions opened this quarter, largest first.

SecurityValueShares% of portfolio
ABVX $53,304,000 400,000 10.07%
ABVX $27,226,884 204,314 5.15%
RARE $20,034,000 600,000 3.79%
DFTX $19,992,000 425,000 3.78%
SGMT $15,691,382 2,029,933 2.97%
IFRX $6,824,288 3,046,557 1.29%
Unknown issuer (CUSIP: G50765109) $5,680,000 500,000 1.07%
ALT $5,293,345 1,741,232 1.00%
Unknown issuer (CUSIP: G0375M101) $5,080,000 500,000 0.96%
Unknown issuer (CUSIP: 811292309) $3,843,268 944,292 0.73%
ELVN $3,552,500 70,000 0.67%
RNTX $2,678,000 2,575,000 0.51%
DBVT $2,573,258 156,906 0.49%

Top movers (QoQ)

10
SecurityActionShares ΔValue Δ
VERA Bought more +401K +$17.8M
AMLX Trimmed -1.1M -$11.8M
NKTR Trimmed -141K -$10.6M
IMMX Bought more +928K +$10.0M
ORKA Price move only +0 +$8.5M
DRUG Trimmed -110K -$8.4M
MLTX Bought more +356K +$7.3M
ANNX Bought more +1.0M +$6.1M
ALMS Price move only +0 +$5.2M
CTNM Bought more +121K +$4.7M

1 position hidden — reported move looks larger than the position itself (data completeness check)

Exited positions

11

Includes corporate events (mergers, delistings) — not all exits are sells

Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.

SecurityQuarterShares beforeValue beforePrice since exit
APGE June 30, 2026 374,000 $31,479,580 No longer tracked
IRON March 31, 2026 250,000 $19,852,500 0.9%
RAPT March 31, 2026 581,187 $19,684,804 No longer tracked
SLNO March 31, 2026 400,000 $18,520,000 No longer tracked
ASND Dec. 31, 2025 75,000 $14,910,750 6.9%
DNTH March 31, 2026 350,000 $14,423,500 5.1%
KALV June 30, 2026 675,000 $13,587,750 No longer tracked
IMVT June 30, 2026 545,625 $13,553,325 -12.7%
JBIO June 30, 2026 964,462 $13,550,691 -36.5%
ABVX Dec. 31, 2025 150,000 $12,735,000 -31.1%
ZBIO June 30, 2026 524,066 $10,245,490 11.5%
VRDN June 30, 2025 750,000 $10,110,000 38.8%
MRUS June 30, 2025 237,156 $9,981,896 No longer tracked
FULC March 31, 2026 800,000 $9,048,000 -51.9%
CYTK Dec. 31, 2025 150,000 $8,244,000 3.2%
UPB March 31, 2026 300,000 $8,145,000 -44.0%
XENE Dec. 31, 2025 200,000 $8,030,000 -15.2%
ASND June 30, 2025 50,000 $7,793,000 32.0%
DVAX June 30, 2025 595,879 $7,728,551 No longer tracked
AKBA Sept. 30, 2025 1,985,915 $7,228,731 -68.3%
CMPX June 30, 2026 1,350,000 $7,141,500 -60.9%
SCYX June 30, 2026 7,554,347 $6,926,581 25.8%
RARE March 31, 2026 300,000 $6,900,000 -27.4%
EOLS Sept. 30, 2025 720,118 $6,632,287 16.3%
ACLX Sept. 30, 2025 100,000 $6,585,000 No longer tracked
CNTX June 30, 2026 2,238,496 $5,864,860 -44.1%
UNCY June 30, 2026 796,558 $5,241,352 -10.0%
TENX June 30, 2026 327,307 $5,233,639 -86.4%
IONS Dec. 31, 2025 80,000 $5,233,600 -45.0%
DNTH June 30, 2025 275,000 $4,988,500 373.5%
AKRO Dec. 31, 2025 103,848 $4,930,703 No longer tracked
TSHA Dec. 31, 2025 1,500,000 $4,905,000 -15.8%
SMMT June 30, 2025 250,000 $4,822,500 -21.3%
PCVX June 30, 2025 115,517 $4,361,922 73.7%
AUTL June 30, 2025 2,728,910 $4,229,811 -21.9%
DBVT Dec. 31, 2025 378,594 $3,785,940 -45.0%
LEGN Dec. 31, 2025 113,460 $3,699,931 -14.6%
KALV Sept. 30, 2025 323,170 $3,653,437 No longer tracked
BEAM June 30, 2025 175,562 $3,428,726 44.0%
CNTA Sept. 30, 2025 225,000 $2,956,500 No longer tracked
MREO June 30, 2025 1,275,000 $2,868,750 -86.0%
SANA March 31, 2026 700,000 $2,849,000 0.3%
ABSI Dec. 31, 2025 796,438 $2,421,172 217.2%
HRMY Dec. 31, 2025 85,000 $2,342,600 5.9%
PHVS June 30, 2026 82,800 $2,339,100 -9.8%
SRRK Sept. 30, 2025 61,607 $2,182,120 25.7%
VYGR June 30, 2025 626,275 $2,116,810 -21.2%
AVTX June 30, 2026 124,666 $1,861,263 -18.9%
ALKS June 30, 2026 50,000 $1,768,000 -20.3%
PMN Sept. 30, 2025 2,645,128 $1,279,713 2086.0%
PLRX Dec. 31, 2025 850,000 $1,258,000 -15.2%
CAPR Dec. 31, 2025 87,700 $632,317 -69.0%
HLXB Sept. 30, 2025 29,381 $312,026 No longer tracked